Harvard scientists have unveiled a new technique called expansion in situ genome sequencing (ExIGS) that combines existing in situ genome sequencing (IGS) with expansion microscopy (ExM). The innovation allowed researchers to link nucleus abnormalities to alterations in gene regulation within a single cell with precise measurements of DNA-protein interactions at the nanometer scale.
